Article section
Genetic Predictors of Lung Cancer Risk: A Molecular Approach Involving microRNA Signatures
Abstract
Lung cancer is a leading cause of cancer-related deaths worldwide, with both environmental and genetic factors contributing to its development. Among genetic determinants, microRNA (miRNA) dysregulation has emerged as a critical mechanism in tumorigenesis. MiR-146a plays a pivotal role in modulating immune and inflammatory responses, and its rs2910164 polymorphism (G>C) has been implicated in cancer susceptibility. This study aimed to investigate the association between the miR-146a rs2910164 polymorphism and lung cancer risk in an Iraqi population. A case-control design was employed, involving 72 patients with histopathologically confirmed lung cancer and 70 age- and gender-matched healthy controls. Genomic DNA was extracted from peripheral blood samples, and the rs2910164 polymorphism was genotyped using Tetra-ARMS PCR. Genotypes were determined by analyzing distinct band patterns on 2% agarose gels. Statistical analyses were performed to compare genotypic and allelic frequencies between cases and controls, calculating odds ratios (OR) with 95% confidence intervals (CI) and p-values. The GC genotype showed a significantly higher frequency among lung cancer cases compared to controls (OR = 2.22, 95% CI: 1.19–4.14; p = 0.004), suggesting a potential risk factor. The C allele also demonstrated a notable association with increased lung cancer susceptibility (OR = 1.79, 95% CI: 1.11–2.89; p = 0.017). In contrast, neither the GG genotype nor the G allele exhibited a significant relationship with disease risk (p > 0.05). Collectively, our findings confirm that carriers of the miR-146a rs2910164 C allele, especially the GC carriers, are at a heightened risk of developing lung cancer in the Iraqi population. To confirm such a finding and elucidate the molecular circuitry of Iraqi carcinogenesis, however, future investigations must be extended: larger, multiethnic cohorts with control for other genetic markers, lifestyle factors, and environmental factors will be required.
Keywords:
Article information
Journal
Journal of Medical Science, Biology, and Chemistry
Volume (Issue)
2(2), (2025)
Pages
22-26
Published
Copyright
Copyright (c) 2025 Hasanain Ali Shubbar (Author)
Open access

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Dezfuli, N. K., Adcock, I. M., Alipoor, S. D., Seyfi, S., Salimi, B., Mafi Golchin, M., ... & Mortaz, E. (2020). The miR‐146a SNP Rs2910164 and miR‐155 SNP rs767649 Are Risk Factors for Non‐Small Cell Lung Cancer in the Iranian Population. Canadian Respiratory Journal, 2020(1), 8179415. https://doi.org/10.1155/2020/8179415
Jia, Y., Zang, A., Shang, Y., Yang, H., Song, Z., Wang, Z., ... & Li, H. (2014). MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population. Medical oncology, 31, 1-5. https://doi.org/10.1007/s12032-014-0194-2
Omar, N. S., & Ali, R. T. (2019). Dosimetric Analysis with Intensity-modulated Radiation Therapy for Central Nervous System Irradiation in Patients with Brain Cancer Compared with Three-dimensional Conformal Radiation Therapy Treatment. Polytechnic Journal, 9(2), 9.
Omar, N. S., Ahmed, F. K., Saleem, D. S., Shah, L. J. A., & Abbas, M. A. (2024). Influence of Maternal Body Mass Index on Fetal Ultrasound Biometry. Cihan University-Erbil Scientific Journal, 8(2), 93-98.
Ren, Y. G., Zhou, X. M., Cui, Z. G., & Hou, G. (2016). Effects of common polymorphisms in miR-146a and miR-196a2 on lung cancer susceptibility: A meta-analysis. Journal of Thoracic Disease, 8(6), 1297–1305. https://doi.org/10.21037/jtd.2016.05.02
Ren, Y. G., Zhou, X. M., Cui, Z. G., & Hou, G. (2016). Effects of common polymorphisms in miR-146a and miR-196a2 on lung cancer susceptibility: A meta-analysis. Journal of Thoracic Disease, 8(6), 1297–1305. https://doi.org/10.21037/jtd.2016.05.02
Wang, J., Wang, Q., Liu, H., Shao, N., Tan, B., Zhang, G., ... & Cheng, Y. (2012). The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis, 27(6), 779-788. https://doi.org/10.1093/mutage/ges052
Wang, J., Wang, Q., Liu, H., Shao, N., Tan, B., Zhang, G., Jia, Y., Ma, W., Wang, N., & Cheng, Y. (2012). The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: A meta-analysis of 32 studies. Mutagenesis, 27(6), 779–788. https://doi.org/10.1093/mutage/ges052
Wistuba, I. I., & Gazdar, A. F. (2006). Lung cancer preneoplasia. Annual Review of Pathology: Mechanisms of Disease, 1, 331–348. https://doi.org/10.1146/annurev.pathol.1.110304.100103
Yin, Z., Cui, Z., Ren, Y., Xia, L., Li, H., & Zhou, B. (2017). MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females. Oncotarget, 8(2), 2275–2283. https://doi.org/10.18632/oncotarget.13917
Zhang, J., Shao, W., Zhang, Z., & Liu, D. (2020). The rate of miR-146a rs2910164 mutations in patients with lung cancer: A meta-analytic review. Translational Cancer Research, 9(11), 6792–6800. https://doi.org/10.21037/tcr-20-2171